AstraZeneca Can't Shake Patent Suit Over Crestor Trials
A South Carolina federal judge refused Friday to dismiss a patent infringement suit AstraZeneca Pharmaceuticals LP faces over a clinical trial of alternative uses for its Crestor cholesterol drug, trimming several...To view the full article, register now.
Already a subscriber? Click here to view full article